- Home
- BANC vs AGIO Comparison
BANC vs AGIO Comparison
Compare BANC & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANC
- AGIO
- Stock Information
- Founded
- BANC 1941
- AGIO 2007
- Country
- BANC United States
- AGIO United States
- Employees
- BANC N/A
- AGIO 386
- Industry
- BANC Major Banks
- AGIO Biotechnology: Pharmaceutical Preparations
- Sector
- BANC Finance
- AGIO Health Care
- Exchange
- BANC Nasdaq
- AGIO Nasdaq
- Market Cap
- BANC 2.8B
- AGIO 2.4B
- IPO Year
- BANC N/A
- AGIO 2013
- Fundamental
- Price
- BANC $16.31
- AGIO $41.69
- Analyst Decision
- BANC Buy
- AGIO Buy
- Analyst Count
- BANC 11
- AGIO 7
- Target Price
- BANC $17.82
- AGIO $56.33
- AVG Volume (30 Days)
- BANC 1.8M
- AGIO 886.0K
- Earning Date
- BANC 01-23-2025
- AGIO 10-31-2024
- Dividend Yield
- BANC 2.41%
- AGIO N/A
- EPS Growth
- BANC N/A
- AGIO N/A
- EPS
- BANC N/A
- AGIO 11.80
- Revenue
- BANC $412,570,000.00
- AGIO $32,871,000.00
- Revenue This Year
- BANC N/A
- AGIO $33.38
- Revenue Next Year
- BANC $9.57
- AGIO $163.06
- P/E Ratio
- BANC N/A
- AGIO $3.53
- Revenue Growth
- BANC N/A
- AGIO 36.79
- 52 Week Low
- BANC $11.88
- AGIO $20.96
- 52 Week High
- BANC $18.08
- AGIO $62.58
- Technical
- Relative Strength Index (RSI)
- BANC 46.70
- AGIO 35.05
- Support Level
- BANC $16.22
- AGIO $37.20
- Resistance Level
- BANC $16.95
- AGIO $44.46
- Average True Range (ATR)
- BANC 0.40
- AGIO 3.88
- MACD
- BANC -0.13
- AGIO -1.96
- Stochastic Oscillator
- BANC 12.27
- AGIO 16.89
About BANC Banc of California Inc.
Banc of California Inc is a financial holding company. It offers banking and financial services. The company's services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.